Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy”

5,268 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,268 results

Not applicableActive Not RecruitingNCT07046195
What this trial is testing

Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer

Who this might be right for
Hypofractionated RadiotherapyTriple Negative Breast Cancer (TNBC)Immunotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 250
Not applicableStudy completedNCT00711139
What this trial is testing

Long-term Safety and Tolerability of AFFITOPE AD01

Who this might be right for
Alzheimer's Disease
Affiris AG 22
Testing effectiveness (Phase 2)Looking for participantsNCT06173219
What this trial is testing

Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

Who this might be right for
Advanced Solid Tumor
China-Japan Friendship Hospital 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06620822
What this trial is testing

Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 296
Early research (Phase 1)UnknownNCT03015922
What this trial is testing

Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leeds 4
Not applicableUnknownNCT05761002
What this trial is testing

Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts

Who this might be right for
Human Papilloma VirusAnogenital Wart
Zagazig University 58
Early research (Phase 1)Study completedNCT04327037
What this trial is testing

Safety of Expanded Haploidentical Natural Killer Cells for Leukemia

Who this might be right for
Leukemia, Acute MyeloidLeukemia, Acute Lymphoblastic
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology 10
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Early research (Phase 1)Study completedNCT01490177
What this trial is testing

Single Center Food Allergy Oral Immunotherapy Study

Who this might be right for
Immune System Diseases
Stanford University 50
Large-scale testing (Phase 3)Study completedNCT00263601
What this trial is testing

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Who this might be right for
Grass Pollen Allergy
Allergopharma GmbH & Co. KG 154
Not applicableUnknownNCT00429065
What this trial is testing

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Who this might be right for
Non-Hodgkin Lymphoma
Instituto Nacional de Cancerologia de Mexico 30
Early research (Phase 1)UnknownNCT04122339
What this trial is testing

MAX-10181 Given Orally to Patients With Advanced Solid Tumor

Who this might be right for
Solid Tumor
Maxinovel Pty., Ltd. 30
Testing effectiveness (Phase 2)WithdrawnNCT02390739
What this trial is testing

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer

Who this might be right for
Metastatic Thyroid Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT03325257
What this trial is testing

Post-ATU Study of Nivolumab

Who this might be right for
Melanoma
Nantes University Hospital 350
Testing effectiveness (Phase 2)WithdrawnNCT05539365
What this trial is testing

Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+1 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01841099
What this trial is testing

Mesalamine in Environmental Enteropathy

Who this might be right for
Malnutrition
Kelsey Jones 44
Testing effectiveness (Phase 2)Study completedNCT01438463
What this trial is testing

PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
HAL Allergy 290
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07157306
What this trial is testing

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Very early researchWithdrawnNCT04220892
What this trial is testing

Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma

Who this might be right for
High Grade Glioma
Jose Carrillo
Testing effectiveness (Phase 2)Study completedNCT02844335
What this trial is testing

Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer

Who this might be right for
Breast Cancer Recurrent
Fuda Cancer Hospital, Guangzhou 60
Load More Results